+1-786-628-7980
Sign Up/Sign In 
Plaque Psoriasis Market Research Report: Information By Treatment (Topical Therapy, Phototherapy, Systemic Agents, Biologic Therapies, and Others), By Route of Administration (Oral, and Injectable), By End Users (Hospitals, Homecare, Speciality Centres, and Others), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, and Retail Pharmacy), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032
The plaque psoriasis market is projected to reach USD 32.7 billion by 2032 at 8.80% CAGR during the forecast period 2023-2032. Plaque psoriasis, a chronic autoimmune skin condition characterized by red, raised, and scaly patches, significantly impacts the global healthcare landscape. The market for plaque psoriasis treatments has witnessed dynamic growth, driven by increasing prevalence and a growing awareness of the disease. With an estimated 125 million people affected worldwide, pharmaceutical companies are investing in innovative therapies to address this unmet medical need.
Market expansion is fueled by strategic collaborations, mergers, and acquisitions, emphasizing research and development for novel therapies. The push for personalized medicine and advancements in understanding psoriasis at a molecular level further contribute to the evolving market dynamics. As research progresses, the plaque psoriasis market is poised for continued innovation and improved patient outcomes.
Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/16119
Competitive Analysis
MRFR recognizes the following companies as the key players in the global plaque psoriasis market— Pfizer Inc.,GlaxoSmithKline plc, Novartis AG , Mylan N.V., Teva Pharmaceutical Industries Ltd., Sanofi, Boehringer Ingelheim International GmbH., AstraZeneca, Johnson & Johnson Private Limited, Bayer AG, Merck & Co., Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company , Cadila Pharmaceuticals, Eli Lilly and Company , LEO Pharma A/S , Cipla Inc. , Aurobindo Pharma , Lupin , Sumitomo Corporation.
Segment Analysis
The global plaque psoriasis market has been segmented based on treatment, route of administration, end use and distribution Channel.
On the basis of treatment, the market is segmented into Topical therapy, Phototherapy, Systemic agents, Biologic therapies and others.
Based on route of administration, the global plaque psoriasis market has been segmented into Power Oral and Injectable.
On the basis of end use, the market is segmented into Hospitals, Homecare, Speciality centres and others.
On the basis of distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy.
Browse In-depth Market Research Report (128 Pages) on Plaque Psoriasis: https://www.marketresearchfuture.com/reports/plaque-psoriasis-market-16119
Regional Analysis
The Plaque Psoriasis Market exhibits dynamic growth globally, fueled by an increasing prevalence of the chronic skin condition.
North America dominates the market, driven by a high incidence of psoriasis, well-established healthcare infrastructure, and robust research and development activities.
Europe follows suit, with a substantial patient population and a focus on innovative treatment options.
The Asia-Pacific region is witnessing significant growth, attributed to rising awareness, improving healthcare facilities, and a growing burden of psoriasis cases.
Developing regions in Latin America and the Middle East also contribute to market expansion as healthcare access improves.
Discover More Research Reports on Healthcare Industry by Market Research Future:
Interventional Neurology Market Research Report – Forecast Till 2032
Musculoskeletal System Disorders Market Research Report – Forecast Till 2032
Lymphedema Diagnostics Market Research Report – Forecast Till 2032
Eye Health Supplements Market Research Report – Forecast Till 2032
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: sales@marketresearchfuture.com
Website: https://www.marketresearchfuture.com
